Interventional Cardiology Market Size, Share & COVID19 Impact Analysis - Global - 2023-2029 - MedSuite - Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more
In 2022, the Global Interventional Cardiology Market was valued at $11 billion. Over the forecast period, it is projected to grow at a CAGR of 2.4% and reach $13 billion.
The comprehensive report suite on the global interventional cardiology market includes various segments such as coronary stent, coronary balloon catheter, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, atherectomy and intravascular lithotripsy (IVL) device, coronary introducer sheath, coronary vascular closure device (VCD), diagnostic catheter and guidewire, optical coherence tomography (OCT) catheter, and intravascular ultrasound (IVUS) catheter markets.
DATA TYPES INCLUDEDUnit Sales, Average Selling Prices, Market Size & Growth Trends
Interventional Cardiology Procedure Volumes
Market Forecasts Until 2029, and Historical Data to 2019
Market Drivers & Limiters for Each Global Interventional Cardiology market
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
COVID19 Impact on the Global Interventional Cardiology market
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL INTERVENTIONAL CARDIOLOGY MARKET INSIGHTSAccess to healthcare and the development of hospital infrastructure in developing countries across Latin America and Asia-Pacific, including China and India, have shown significant improvement. As a result, more individuals worldwide are able to undergo interventional procedures, leading to the expansion of the device market. The forecasted trend for the future indicates a continuous decline in prices, primarily influenced by market consolidation and bundling practices. With numerous competitors in the market, it has become common for devices to be bundled together at a lower price in order to boost overall sales. The utilization of intravascular imaging technologies varies across different regions worldwide. Currently, North America and Asia Pacific exhibit the highest adoption rates, demonstrating widespread usage of these devices. In contrast, other regions are experiencing a gradual yet steady increase in the implementation of this technology.
GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE INSIGHTIn 2022, three major players, namely Boston Scientific, Abbott, and Medtronic, dominated the global interventional cardiology market. Boston Scientific emerged as the leader in several segments, including coronary stents, balloon catheters, and embolic protection devices. The company's extensive range of devices, coupled with its international sales team, enabled it to maintain its dominant position.
Abbott excelled in the interventional coronary guidewire and OCT catheter markets, particularly in Western Europe. The Xience™ drug-eluting stent, known for its effectiveness in chronic total occlusion (CTO) cases, gained significant traction in terms of units sold.
Medtronic showcased its presence across multiple market segments, including coronary stents, balloon catheters, interventional coronary catheters, diagnostic catheters and guidewires, as well as embolic protection devices and coronary introducer sheaths. The company's notable performance was observed in the interventional coronary catheter market, where it offered product lines such as Launcher®, Sherpa NX™ Active, Sherpa NX™ Balanced, and Telescope™ under its portfolio.
REPORT GEOGRAPHIC COVERAGEThroughout this research series, iData Research has extensively examined and analyzed several regions. The regions covered in our research include:
North America (United States and Canada)
Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
Central and Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
Africa( South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
DETAILED MARKET SEGMENTATIONWhile the MedSuite report provides comprehensive analysis and data for the Global Interventional Cardiology Devices market, we also offer individual MedCore reports for each market segment. This allows you to access specific market research that is relevant to your needs.
Coronary Stent Market – MedCore
Coronary Balloon Catheter Market – MedCore
Interventional Coronary Catheter Market – MedCore
Interventional Coronary Guidewire Market – MedCore
Coronary Embolic Protection Device Market – MedCore
Coronary Atherectomy & Intravascular Lithotripsy (IVL) Device Market – MedCore
Coronary Introducer Sheath Market – MedCore
Coronary Vascular Closure Device (VCD) Market – MedCore
Diagnostic Coronary Catheter & Guidewire Market – MedCore
Intravascular Ultrasound (IVUS) Market – MedCore
Coronary Optical Coherency Tomography Catheter Market – MedCore
RESEARCH SCOPE SUMMARYRegions: North America (United States and Canada), Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other), Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other), Central & Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other), Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other), Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.